Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. lessened its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 12.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 6,745 shares of the biotechnology company’s stock after selling 966 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Axon Enterprise were worth $4,009,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Prestige Wealth Management Group LLC lifted its stake in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at $40,000. Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth $41,000. Planning Capital Management Corp grew its stake in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Finally, Friedenthal Financial purchased a new position in Axon Enterprise in the third quarter valued at $51,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.5 %

AXON stock opened at $677.40 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company’s 50 day simple moving average is $622.79 and its 200-day simple moving average is $491.30. The firm has a market capitalization of $51.66 billion, a PE ratio of 175.04, a P/E/G ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $255.68 and a 12 month high of $698.67.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities raised their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Insider Activity at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.